Singular Genomics Systems: David Barker, Lawrence Fong, David Ledbetter, Elaine Mardis, Daniel Shoemaker

Singular Genomics Systems has formed a scientific advisory board comprising David Barker, Lawrence Fong, David Ledbetter, Elaine Mardis, and Daniel Shoemaker.

Barker, also a member of the firm's board of directors, is a former Illumina chief scientific officer. He is also board chair at Bionano Genomics. He holds a doctorate in biochemistry from Brandeis University.

Fong is a professor of cancer biology at the University of California, San Francisco and codirector of the Parker Institute of Cancer Immunotherapy. He holds an MD from Stanford University.

Ledbetter is chief clinical and research officer at Unified Patient Network. He holds a doctorate from the University of Texas-Austin.

Mardis, also a board member, is coexecutive director of the Institute of Genomic Medicine at Nationwide Children's Hospital. A former president of the American Association for Cancer Research, she holds a doctorate in chemistry and biochemistry from the University of Oklahoma.

Shoemaker is formerly CSO at Fate Therapeutics. He holds a doctorate in biochemistry from Stanford.